Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs

BACKGROUND: Sequential monotherapies of nucleotide analogs used in chronic hepatitis B treatment can lead to the selection of a resistance mutation to each antiviral drug. CASE PRESENTATION: A patient with chronic hepatitis B was successively treated with lamivudine monotherapy, lamivudine-adefovir...

Descripción completa

Detalles Bibliográficos
Autores principales: Larrat, Sylvie, Hilleret, Marie-Noëlle, Germi, Raphaele, Lupo, Julien, Nicod, Sandrine, Zarski, Jean-Pierre, Seigneurin, Jean-Marie, Morand, Patrice
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322943/
https://www.ncbi.nlm.nih.gov/pubmed/18336716
http://dx.doi.org/10.1186/1476-5926-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322943/
https://www.ncbi.nlm.nih.gov/pubmed/18336716
http://dx.doi.org/10.1186/1476-5926-7-3

Ejemplares similares